S
EASONAL influenza vaccination has been recommended and practiced globally, but its efficacy among older nursing home residents remains controversial. The small number of randomized placebo-controlled trials on seasonal influenza vaccination conducted to date have focused mainly on healthy older adults living in the community (1, 2) . However, the highest mortality rate from influenza-related complication occurs in older nursing home residents (3, 4) . Data on the efficacy on this group of people were largely derived from cohorts and case control studies (5) , and a systematic review by Jefferson et al. (6) has suggested that with good vaccine match and high viral circulation, influenza vaccination can reduce mortality in older nursing home residents. This study has been criticized for overestimating the efficacy of influenza vaccination, as the functional status of the participants has not been considered, which can lead to frailty selection bias (7, 8) . Measurement of the functional status in older adults has been suggested by some authors to minimize frailty selection bias (9, 10) . However, few influenza vaccine studies have considered the functional status of the older adults.
In June 2009, the World Health Organization declared that infection by the novel strain of swine-origin Influenza A H1N1 2009 was a pandemic. This virus also resulted in significant hospitalizations and mortality in Hong Kong. During the first wave up to December 2009, the H1N1 attack rate in Hong Kong was 10.7%, and more than 90% of the respiratory viruses isolated from all nasopharyngeal aspirate samples were H1N1 according to a laboratory surveillance by the Hong Kong Centre of Health Protection (CHP [11] ). Case hospitalization rate was nearly 1%, and infected patients above the age of 50 years had 66
Downloaded from https://academic.oup.com/biomedgerontology/article-abstract/68/3/324/707262 by guest on 02 August 2018 times the mortality risk of infected younger patients (12) . Neuraminidase inhibitors, the only antiviral licensed for clinical use in the treatment of influenza, is ineffective in clearing virus in late presenters (13) . Prevention by vaccination has become the most important mean to combat against the H1N1 pandemics.
The CHP began a government-funded H1N1 monovalent vaccination program for adults aged more than 65 in December 2009. This vaccination program was offered in addition to the annual seasonal trivalent influenza vaccination program, but less than 3% of the Hong Kong population has received the vaccination due to fear of the potential adverse effects (14, 15) . Dual vaccination with the monovalent H1N1 vaccine (H1N1) and the seasonal trivalent influenza vaccine (TIV) has been shown to provide additional benefit in reducing all-cause mortality and hospitalization compared with single or no vaccination (16) . Nevertheless, the efficacy of influenza vaccine in relation to the functional status of the elderly participants remains unknown. We therefore performed this study to examine the association between the functional status of the older nursing home residents and the efficacy of influenza vaccination. We hypothesized that although influenza vaccination was efficacious in older adults, their functional status could have an impact on the efficacy of the vaccination.
Methods

Study Design
Study sites and participants.-This study was performed in the Hong Kong West Cluster (HKWC), one of the seven major health districts in Hong Kong. In 2009, there were more than 6,000 older adults living in more than 70 nursing homes in HKWC. In Hong Kong, nursing homes are broadly divided into those privately owned (Private Nursing Homes) and those operated by charitable nonprofit making organization (C&A Homes). All C&A Homes are standardized in staff-to-resident ratio, facility, and quality of care (17) . Nine C&A Homes in the HKWC were included in this study. Older residents who were more than 65 years of age were included. This study was approved by the institutional review boards at the University of Hong Kong and the Hospital Authority.
Data Collection
The functional status of these participants was assessed using the Barthel Index [BI] . The BI is a validated functional status scale that measures performance in basic activities of daily living (BADL) (18) . It consists of 10 variables describing activities of daily living and mobility. A higher score indicates better functional status. It is regarded as a reliable tool for measuring functional status of the older adults (19) . A score of 60 or less has been suggested to be the cutoff point for poor functional status that correlate with poor rehabilitation outcome, and a score of 0 reflects total dependence in activities of daily living (20) . In this study, older adults were divided into three groups according to their BI score: the Good Functional status group (GF group) with BI > 60; the intermediate functional status group (IF group) with BI = 5-60; and the poor functional status group (PF group) with BI = 0. Two independent investigators performed and calculated the BI on all participants.
The CHP provides seasonal influenza vaccination for older adults living in nursing homes between October and November every year. In November 2009, an additional vaccination of H1N1 was offered. The vaccination status of every participant was prospectively recorded after administration of the vaccines. The participants were vaccinated according to their informed choices, which included dual H1N1 and TIV vaccination (H1N1-TIV) or TIV vaccination alone (TIV alone), or to remain unvaccinated if they refused both vaccinations.
Baseline demographic data including age, gender, smoking history, and mode of nutritional intake (ie per oral intake or non-oral, eg nasogastric tube or percutaneous endoscopic gastrostomy tube) were retrieved from the computer management system (CMS) and patient consultation record. Comorbid conditions, coded in the form of The International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM), were collected. The degree of comorbidity was then quantified using the Charlson comorbidity index (CCI [21] [22] [23] [24] ).
Cognitive status of all participants was assessed using the Abbreviated Mental Test (AMT). The AMT is a validated screening test for cognitive impairment in older people. A modified Hong Kong version had been validated in 1995 (25) . Two independent investigators performed and calculated AMT for all participants.
Older adults with multiple comorbidities and functional decline often require hospitalization in their last few years of life, leading to further functional decline and comorbidities (26, 27) . Frequency of hospitalization may serve to identify older adults who are at higher risk of mortality. Therefore, the number of non-scheduled hospitalizations between December 2008 and November 2009, named as "hospitalization in the preceding year" of the participants, was recorded. As the presence of advance directive may affect subsequent choice of vaccination, these data were also collected. The participant's nursing home was taken as "the nursing homes of origin."
Outcome Measures
The clinical status of all participants was monitored from December 2009 to November 2010 by retrieving their in-patient records and out-patient notes from the CMS. The outcome measure was all-cause mortality during the study period.
Statistics
Statistical Package for Social Science (Windows version 18; SPSS Inc., Chicago, IL) was used in statistical analysis. Continuous variables were expressed as mean ± standard deviation (M ± SD) and median with interquartile range as appropriate, and categorical variables were presented in frequency tables. Statistical comparisons of continuous variables were performed using the analysis of variance (ANOVA) and Kruskal-Wallis tests as appropriate, whereas categorical variables were compared using the chi-square test and Fisher's exact test.
For each functional status group, Kaplan-Meier curves were constructed to illustrate the cumulative all-cause mortality of participants with different vaccination statuses during the 12-month follow-up period, and mortality rates were compared using the log-rank test. Participants within each functional status group were further stratified by vaccination status (ie H1N1-TIV, TIV alone, or unvaccinated), and the hazard ratio (HR) of all-cause mortality for each stratum (H1N1-TIV vs TIV alone, H1N1-TIV vs unvaccinated, and TIV alone vs unvaccinated) was determined using the multivariable Cox proportional hazard model with adjustment for age, gender, smoking status, mode of nutritional intake, CCI, BI, AMT, the nursing home of origin and hospitalization in the preceding year. Efficacy was defined as one minus HR of all-cause mortality (1 − HR). Statistical significance was inferred by a two-tailed p value of .05 or less.
Results
A total of 711 participants were enrolled: good functional status group (GF group), 230 (32.3%); intermediate functional status group (IF group), 246 (34.6%); and poor functional status group (PF group), 235 (33.1%). Among the 711 participants, 274 (38.5%) received H1N1 and TIV vaccination, 368 (51.8%) received TIV alone, and 69 (9.7%) were unvaccinated. There were no differences in age, gender, CCI, AMT, smoking history, mode of nutritional intake, and hospitalization in the preceding year regardless of vaccination status within each functional status group (Table 1) . None of the participants had advance directive.
Mortality of Different Vaccination Statuses in Different Functional Status Groups
At 12 months, the mortality rates in the GF group were 3.7% (3 of 81) for those who received H1N1-TIV, 10.2% (13 of 127) for those who received TIV alone, and 27.3% (6 of 22) for those who were unvaccinated. The difference in mortality was significant (p < .001; Figure 1A ). The 12-month mortality rates in the IF group were 10.2% (10 of 98) for those who received H1N1-TIV, 22.0% (27 of 123) for those who received TIV alone, and 28.0% (7 of 25) for those who were unvaccinated participants (p < .001; Figure 1B) . Finally, the 12-month mortality rates in the PF group were 16.8% (16 of 95) for those who received H1N1-TIV, 28.0% (33 of 118) for those who received TIV alone, and 31.8% (7 of 22) for those who were unvaccinated (p < .001; Figure 1C ).
Efficacy of Different Vaccination Statuses on All-cause Mortality in Different Functional Status Groups
The HRs of all-cause mortality of different vaccination statuses in different functional status groups are shown in Table 2 . In the GF group, the HR of H1N1-TIV was 0. 
Discussion
Our study showed that the 12-month all-cause mortality was highest among those unvaccinated participants and lowest among those H1N1-TIV vaccinated participants across all three functional status groups. Nevertheless, the efficacy of vaccination to reduce mortality (H1N1-TIV vs TIV alone, H1N1-TIV vs unvaccinated, and TIV alone vs unvaccinated) declined with increasingly impaired functional status. Our findings are consistent with previous immunological studies, which demonstrated that vaccination-induced immune response was related to the functional status of the individuals, with better immune response demonstrated among those with good functional status (28-31). To our knowledge, this is the first study to show an association between the functional status of the older nursing home residents and the efficacy of influenza vaccination in reducing all-cause mortality. It should be emphasized that although the vaccination efficacy was shown to be the lowest in the PF group, influenza vaccination still significantly reduced all-cause mortality compared with no vaccination. Therefore, it is important to promote influenza vaccination in nursing home residents regardless of their functional status.
Functional status is an important confounding factor for all-cause mortality in both hospitalized and community-dwelling older adults (32) (33) (34) (35) (36) (37) . Our study has suggested that functional status of older nursing home residents affects vaccine efficacy. This contradicts previous findings, which did not detect any interaction between influenza vaccination efficacy and the functional status of those vaccinated (38, 39) . The difference in findings may be due to the different functional assessment instruments used (40) . The functional assessment used in this study was BI, which has been well validated to measure the BADL in different populations. This tool captures the ability to independently bathe, dress, groom, eat, move from bed to chair, toilet, and maintain continence. It is a sensitive tool with good stratifying properties, and it has been shown to be a major determinant of survival after pneumonia in older nursing home residents (41). We did not make any assessment for instrumental activities of daily living (eg preparing meal, performing household tasks, taking medications) because these activities are performed by nursing home staff in Hong Kong. Another important factor is the time at which functional status assessment is performed. The high mortality in our studied population suggests that significant deterioration of functional status can take place over a short period of time. If the functional assessment is performed in the distant past or was simply retrieved from administrative data, the information will not be representative of their true clinical condition. In our study, assessments of the BI were performed within 2 months before vaccination by two geriatricians, ensuring that the information obtained was updated and accurate for all participants.
There were several limitations in this study. Firstly, there were only 69 unvaccinated participants as a result of the patients' choice. The reasons for refusal are unclear and may reflect unmeasured confounders. On the other hand, the sample sizes of the H1N1-TIV and TIV alone vaccination status were relatively large. Secondly, the vaccine efficacy beared a linear relationship with the functional status of the participants in this study but this relationship should be interpreted with caution. Such relationship might not be linear if the sample size was larger, and the participants were categorized into smaller groups. Further study with larger sample size is necessary to clarify this relationship. Thirdly, CCI might not be able to capture the large variability in disease severity within a given disease, and it might contribute to underestimation of comorbidity status of a significant proportion of the participants. Fourthly, in terms of outcome measurement, we did not collect data for laboratory-confirmed influenza, which would be a direct evidence for influenza infection. Measurement of all-cause mortality could only provide indirect estimation of the efficacy. Fifthly, we did not measure immune response toward vaccination in our participants, which could demonstrate a direct relationship between functional status and immune response. Finally, we focused our study on older adults living in C&A Homes, and the results will need to be applied to other population (eg older residents of private nursing home) with caution. Further study involving a larger sample size and participants from private nursing home or the community might give us further evidence on the efficacy of vaccine in older adults.
In conclusion, influenza vaccination was effective in reducing all-cause mortality in older adults residing in nursing home irrespective to their functional status. Vaccine efficacy in reducing mortality appeared to decline with increasingly impaired functional status. To provide a better estimation of vaccine efficacy, updated functional status assessment for nursing home residents by validated functional assessment instrument is essential for future study on vaccine efficacy. ||p < .05. ¶p < .01.
